Banner

Serum Interleukin-2 Level in Children with Attention-Deficit Hyperactivity Disorder (ADHD)

• 2022
Back
Publication Information
Authors Aliaa M. Diab1, Ghada S. Abdelmotaleb1, Mosad Fatouh Rashed3, Aliaa M. Diaba, Elham Abdel Ghaffara, Doaa R. Solimana, Shewikar El Bakryb, Mona N. El Hasaba
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type Local
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background: Attention deficit hyperactivity disorder (ADHD) etiology is not completely understood, but common comorbid dysfunction of immune system suggest that these systems may be affected by common genetic background and molecular mechanism, for example, increase levels of specific cytokines are observed in ADHD. The aim of this study was to evaluate the level of inerleukin-2 (IL-2) as a biomarker of ADHD and find out the relation between interleukin-2 and ADHD symptoms. Patients and Methods: A case control study carried out on 90 children who assigned into two equal groups: ADHD patients: met diagnosis of ADHD according to DSM V criteria and a control group. All groups were subjected to full history taken, thorough clinical examination , and measurement of Human IL-2 by ELISA technique. Results: The mean value of IL2 level was statistically significantly higher among ADHD cases than control group (p